Published • loading... • Updated
Euronext Brussels: Argenx Leads the Bel20 Thanks to FDA Approval
Summary by De Tijd
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
12:12 Although European stock markets are turning light red, the Bel20 is rallying. Heavyweight Argenx is gaining ground after the FDA gave the green light for the widespread use of Vyvgart in the rare muscle disease...
·Belgium
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
